He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease.

Annovis Bio (NYSE: ANVS) , a late-stage clinical drug platform company focused on therapies for neurodegenerative diseases, disclosed it received a n ...

ABC primetime television event features frank disclosures about aging from Halle Berry, Naomi Watts, Maria Shriver, medical ...

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...

Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative ...

In people with dementia, emotions remain long after their words become unreachable, so this longing for comfort is expressed as wanting to go home.

President Donald Trump reiterated his desire Friday to control Greenland, telling reporters in the Oval Office that it’s ...

Meredith Grey, one of the protagonists in Grey's Anatomy, has remained a be a loved character despite her professional ...

Barbara Franchin, the force behind Trieste’s emerging designer contest ITS since 2002, has an unrelenting drive. Following ...

ACP-204 that completed phase II clinical trial for the treatment of Alzheimer’s disease psychosis and Lewy Body Dementia with psychosis; ACP-711, which is in phase I clinical trial for the ...

and psychosis and agitation in patients with Alzheimer’s disease; ITI-1020 in Phase 1 trial for cancer immunotherapy; and ITI-1549 in preclinical studies for mood and anxiety disorders.